ArticleStem cell research & therapy2025

CXCR5-engineered mesenchymal stromal cells home to spleen and mitigate post-sepsis syndrome by preventing secondary infection.

Jiahao Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.